Would be interesting to normalize by # of tests. At least until age groups of 70-79 and 80+ the 3 dose cohort underwent much more tests. pic.twitter.com/OZlVljfIt2— H_M_X_ (@hmatejx) May 12, 2022
Would be interesting to normalize by # of tests. At least until age groups of 70-79 and 80+ the 3 dose cohort underwent much more tests. pic.twitter.com/OZlVljfIt2